Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 210009, PR China.
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Feb 15;917-918:93-9. doi: 10.1016/j.jchromb.2012.12.029. Epub 2013 Jan 8.
A high performance liquid chromatography-hydride generation-atomic fluorescence spectrometry (HPLC-HG-AFS) method was developed for the simultaneous determination of four arsenic species (As(III), dimethylarsinic acid (DMA), monomethylarsonic acid (MMA) and arsenate As(V)) in dog plasma. Good separation of the four arsenic species was achieved within 15min on an anion-exchange column with isocratic elution using 15mmol/L KH(2)PO(4) (pH 5.9) as eluent at a flow rate of 1.0mL/min. The assay was linear over the range of 1.25-200, 1.56-200, 1.34-172, and 2.50-200ng/mL with the detection limits of 0.80, 1.00, 0.86 and 2.00ng/mL for As(III), DMA, MMA and As(V), respectively. The method was validated for selectivity, precision, accuracy and recovery and then applied to a comparative pharmacokinetic study of the arsenic species in beagle dogs after a single oral administration of Realgar (24.32mg/kg, equivalent to 11.31mgAs/kg) alone or Niu Huang Jie Du Pian (a patent traditional Chinese medicine (TCM), 380mg/kg, equivalent to 28.45mgAs/kg), respectively. DMA was found to be the predominant species in the dog plasma after dosing, with As(V) appeared as the quickly eliminating one. No traces of MMA and As(III) were detected at any sampling time points. The main pharmacokinetic parameters found for DMA p.o. administration of Realgar and Niu Huang Jie Du Pian were as follows: C(max) (14.7±4.2) and (57.0±32.0)ng/mL, T(max) (2.4±0.5) and (2.5±0.5)h, AUC(0-36) (151.1±12.9) and (635.9±418.2)ngh/mL, AUC(0-∞) (206.0±44.5) and (687.2±425.1)ngh/mL, t(1/2) (16.2±7.9) and (9.4±2.2)h, respectively. The influence of compounding in Niu Huang Jie Du Pian on the pharmacokinetics of arsenics was shown with increased transformation of DMA and its faster elimination rate.
建立了一种高效液相色谱-氢化物发生-原子荧光光谱法(HPLC-HG-AFS),用于同时测定犬血浆中的四种砷形态(As(III)、二甲基砷酸(DMA)、一甲基砷酸(MMA)和砷酸盐 As(V))。在阴离子交换柱上,以 15mmol/LKH(2)PO(4)(pH5.9)为流动相,流速为 1.0mL/min,等度洗脱,可在 15min 内实现四种砷形态的良好分离。As(III)、DMA、MMA 和 As(V)的检测限分别为 0.80、1.00、0.86 和 2.00ng/mL,线性范围分别为 1.25-200、1.56-200、1.34-172 和 2.50-200ng/mL。该方法经过选择性、精密度、准确性和回收率验证,然后应用于单次口服雄黄(24.32mg/kg,相当于 11.31mgAs/kg)或牛黄解毒片(一种专利中药(TCM),380mg/kg,相当于 28.45mgAs/kg)后犬血浆中砷形态的比较药代动力学研究。给药后,犬血浆中以 DMA 为主,As(V)为快速消除型。在任何采样时间点均未检测到 MMA 和 As(III)。雄黄和牛黄解毒片口服后 DMA 的主要药代动力学参数如下:C(max)(14.7±4.2)和(57.0±32.0)ng/mL,T(max)(2.4±0.5)和(2.5±0.5)h,AUC(0-36)(151.1±12.9)和(635.9±418.2)ngh/mL,AUC(0-∞)(206.0±44.5)和(687.2±425.1)ngh/mL,t(1/2)(16.2±7.9)和(9.4±2.2)h。牛黄解毒片配伍对砷药代动力学的影响表现为 DMA 转化率增加,消除率加快。